Health Condition 1: B99-B99- Other infectious diseases
Conditions
Interventions
Intervention1: Rapid Diagnostic tests: The diagnostic tests to be used in the intervention package will be selected from the following:
Specific Point of Care (PoCs) already commercially registered in
Sponsors
Foundation for Innovative New Diagnostics
Eligibility
Inclusion criteria
Inclusion criteria: A. Patients with fever with no focus / RTI: a. Children (6 months to b. Presenting with an acute febrile illness defined as temperature of >37.5°C or history of fever within the last 7 days with no focus or suspected RTI. c. Parent/guardian providing written informed consent for their children if d. Obtain assent for adolescents between 12 and e. Willing to provide blood samples and adhere to study procedures explained in the consent forms following the protocol. f. Available and willing to return for follow-up visit at the health facility. B. Training and communication (for those randomised to intervention arm): a. Parent/guardian providing informed consent to participate in the training and communication component of the study. b. Clinic staff who have provided written informed consent to participate in the training and communication as per randomisation protocol
Exclusion criteria
Exclusion criteria: Participants are excluded using the following exclusion criteria: o Children and adolescents from 6 months to o Patients with acute febrile illness outside the allowed age range. o Severely ill patients requiring hospital admission or referral as assessed by the study clinicians. o Anyone refusing consent to the study or not available for follow-up (adults, the children of parents/guardians, or adolescents who refuse or are missed when asking for consent).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Proportion of outpatient cases of acute febrile illness with favourable outcome (defined as being alive and asymptomatic) 2. Rates of antibiotic prescriptions for acute febrile illness in the clinic Timepoint: 1. at 2 weeks 2. at baseline clinical consult | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Adherence to new algorithm by health care workers 2 Adherence to prescription by patients/caregivers. 3 Rates of adverse eventsTimepoint: During study | — |
Countries
India
Contacts
Public ContactDr Gajanan Baburao Phutke
Jan Swasthya Sahyog (JSS), Ganiyari
Outcome results
None listed